Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes



Rating:

Share or cite this content

Citations should be made in the following way:
L. Grassion (Pessac, France), S. Jaffre (Nantes, France), M. Georges (Dijon, France), S. Pontier (Toulouse, France), J. Soler (Vandœuvre-lès-Nancy, France), P. Peñacoba (Barcelona, Spain), J. Arnal (Toulon, France), C. Saint Raymond (Grenoble, France), A. Prigent (rennes, France), M. Mineiro (Lisboa, Portugal), W. Trzepizur (Angers, France), B. Conde (Vila Real, Portugal), C. Rabec (Dijon, France), J. Winck (Porto, Portugal), P. Anton (Barcelona, Spain), J. Gonzalez-Bermejo (Paris, France). Rescue2-Monitor (R2M) study: an overview of screened patients.. 3569

Member's Comments

No comment yet.

Related content which might interest you: Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 How to make me like your paper (part 1) Source: ERS Lung Science Conference 2021 Year: 2021 How to make me like your paper (part 2) Source: ERS Lung Science Conference 2021 Year: 2021 Use of 6-min (6M) and 12 min (12M) walking test (WT) for assessing the efficacy of formoterol (F) Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007 The effect of reverse causation (RC) and confounding-by-indication (CbI) on the association between infant antibiotic use and asthma risk – A systematic review and meta-analysis Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma Year: 2010 More than 50% of patients visit a general practitioner (GP), general physician (Gen P) or a pediatrician (P) in India for respiratory symptoms: Results of a one-day point-prevalence study in 2,04,912 patients across 22 states and 5 union territories in India Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012 Valdation study of MEP-questionnaire for detection of exacerbations (Ebs) - interim analysis Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Late Breaking Abstract - Tocilizumab (T) plus pembrolizumab (P) in patients (pts) with Covid-19 pneumonia: COPERNICO Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome Year: 2021 Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 An observational study of the severity of respiratory depression (RDP) in opioid dependent patients (ODP). Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2) Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Pooled analyses of five phase 2b studies support dose selection of glycopyrrolate-formoterol (GFF) MDI (PT003) 18/9.6 μg for phase III development Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Asthma control in Latin america (LA) and Caribbean (CAR) countries: correlation between asthma control test (ACT), FEV1 and current treatment Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Validation of the asthma control questionnaire in children (6-16 years) Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009 COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level Source: Annual Congress 2012 - COPD exacerbation Year: 2012 How (molecular) pathologists can profile patients Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Patients‘ perception of their own influence on asthma (locus of control). Results from an observational study Source: Eur Respir J 2007; 30: Suppl. 51, 147s Year: 2007 Safety, pharmacodynamics (PD) and pharmacokinetics (PK) of darotropium (DARO) and vilanterol (VI) in healthy subjects: Two phase 1 studies Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013